Ann: Avita Medical CEO Shareholder Letter, page-15

@huonscott, we are talking about a potentially large market where second or third largest market share would still be extremely lucrative.

I still shake my head in awe at the recent letter to shareholders by our new CEO. I have never read anything released by an ASX listed company before and been more impressed. It was that good!

For making good $$$'s on listed biotechs, I believe that a good CEO is probably even more important than a good product. I think we now have a CEO that understands the game, is clearly entrepreneurial and will focus his energy on making real progress that will benefit AVH shareholders with a rising share price.

We all know our product works and it is a huge endorsement that the US military is keen to continue trialling our product. I think that speaks volumes in itself. They are a large market in their own right.

I'm pretty confident AVH has finally turned the corner.